These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9179655)

  • 1. Liposomal amphotericin B and recombinant human granulocyte-macrophage colony-stimulating factor (rHuGM-CSF) in the treatment of paediatric AIDS-related cryptococcosis.
    Manfredi R; Coronado OV; Mastroianni A; Chiodo F
    Int J STD AIDS; 1997 Jun; 8(6):406-8. PubMed ID: 9179655
    [No Abstract]   [Full Text] [Related]  

  • 2. Liposomal amphotericin B and rHuGM-CSF for treatment of visceral leishmaniasis in AIDS.
    Mastroianni A
    Infez Med; 2004 Sep; 12(3):197-204. PubMed ID: 15711134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paranasal sinus mucormycosis in an immunocompetent host: efficacy and safety of combination therapy with Liposomal Amphotericin B and adjuvant rHuGM-CSF.
    Mastroianni A
    Infez Med; 2004 Dec; 12(4):278-83. PubMed ID: 15729020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential utility of recombinant human GM-CSF as adjunctive treatment of refractory oropharyngeal candidiasis in AIDS patients.
    Vazquez JA; Gupta S; Villanueva A
    Eur J Clin Microbiol Infect Dis; 1998 Nov; 17(11):781-3. PubMed ID: 9923519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anaphylaxis due to liposomal amphotericin (AmBisome).
    Bates CM; Carey PB; Hind CR
    Genitourin Med; 1995 Dec; 71(6):414. PubMed ID: 8566990
    [No Abstract]   [Full Text] [Related]  

  • 6. The management of cryptococcal disease in patients with AIDS.
    Bozzette SA
    Curr Clin Top Infect Dis; 1993; 13():250-68. PubMed ID: 8397913
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of cryptococcosis with liposomal amphotericin B (AmBisome) in 23 patients with AIDS.
    Coker RJ; Viviani M; Gazzard BG; Du Pont B; Pohle HD; Murphy SM; Atouguia J; Champalimaud JL; Harris JR
    AIDS; 1993 Jun; 7(6):829-35. PubMed ID: 8363759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrence of two different opportunistic mycoses complicated by visceral dissemination diagnosed in "AIDS presenter" patients: candidiasis and cryptococcosis.
    Manfredi R; Calza L
    J Chemother; 2007 Jun; 19(3):350-1. PubMed ID: 17594935
    [No Abstract]   [Full Text] [Related]  

  • 9. Lipid-based amphotericin B in the treatment of cryptococcosis.
    Viviani MA; Rizzardini G; Tortorano AM; Fasan M; Capetti A; Roverselli AM; Gringeri A; Suter F
    Infection; 1994; 22(2):137-42. PubMed ID: 7915255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current approach to the acute management of cryptococcal infections.
    Powderly WG
    J Infect; 2000 Jul; 41(1):18-22. PubMed ID: 11041709
    [No Abstract]   [Full Text] [Related]  

  • 11. Amphotericin B as primary therapy for cryptococcosis in patients with AIDS: reliability of relatively high doses over a relatively short period.
    Churchill D; Coker R
    Clin Infect Dis; 1995 Nov; 21(5):1352-3. PubMed ID: 8589187
    [No Abstract]   [Full Text] [Related]  

  • 12. Discontinuation of secondary prophylaxis against cryptococcosis in patients with AIDS receiving highly active antiretroviral therapy.
    Rollot F; Bossi P; Tubiana R; Caumes E; Zeller V; Katlama C; Bricaire F
    AIDS; 2001 Jul; 15(11):1448-9. PubMed ID: 11504971
    [No Abstract]   [Full Text] [Related]  

  • 13. [Tenosynovitis caused by Cryptococcus neoformans in a patient with AIDS].
    Fernández CM; Enrique Morano L; Angel Montero L
    Enferm Infecc Microbiol Clin; 2001; 19(6):285-6. PubMed ID: 11440675
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy of liposomal amphotericin B combined with gamma interferon or granulocyte-macrophage colony-stimulating factor for treatment of systemic zygomycosis in mice.
    Rodríguez MM; Calvo E; Mariné M; Pastor FJ; Fernandez-Ballart J; Guarro J
    Antimicrob Agents Chemother; 2009 Aug; 53(8):3569-71. PubMed ID: 19451289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-course treatment and response to liposomal amphotericin B in AIDS-associated cryptococcosis.
    Coker R; Horner PJ
    J Infect Dis; 1992 Mar; 165(3):593. PubMed ID: 1538170
    [No Abstract]   [Full Text] [Related]  

  • 16. Cryptococcosis.
    Aberg JA; Powderly WG
    Adv Pharmacol; 1997; 37():215-51. PubMed ID: 8891103
    [No Abstract]   [Full Text] [Related]  

  • 17. Liposomal amphotericin B and granulocyte colony-stimulating factor therapy in a murine model of invasive infection by Scedosporium prolificans.
    Ortoneda M; Capilla J; Pujol I; Pastor FJ; Mayayo E; Fernández-Ballart J; Guarro J
    J Antimicrob Chemother; 2002 Mar; 49(3):525-9. PubMed ID: 11864953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Port-a-cath-related Fusarium oxysporum infection in an HIV-infected patient: treatment with liposomal amphotericin B.
    Eljaschewitsch J; Sandfort J; Tintelnot K; Horbach I; Ruf B
    Mycoses; 1996; 39(3-4):115-9. PubMed ID: 8767004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cryptococcosis: we should do better!
    Antinori S
    Clin Infect Dis; 2006 Oct; 43(7):948-9; author reply 949-50. PubMed ID: 16941382
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical cases in Medical Mycology. Case No. 30].
    Maiolo E; Arechavala AI; Santiso G; Bianchi MH; Troglio F; Orduna T; Negroni R
    Rev Iberoam Micol; 2007 Dec; 24(4):330-1. PubMed ID: 18095773
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.